Literature DB >> 27017056

A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets.

Victor I Ayala1, Matthew T Trivett1, Lori V Coren1, Sumiti Jain1, Patrick S Bohn2, Roger W Wiseman2, David H O'Connor2, Claes Ohlen1, David E Ott3.   

Abstract

To study CD4(+)T-cell suppression of AIDS virus replication, we isolated nine rhesus macaque SIVGag-specific CD4(+)T-cell clones. One responding clone, Gag68, produced a typical cytotoxic CD8(+)T-cell response: induction of intracellular IFN-γ, MIP-1α, MIP-1β, and CD107a degranulation. Gag68 effectively suppressed the spread of SIVmac239 in CD4(+)T cells with a corresponding reduction of infected Gag68 effector cells, suggesting that CD4(+)effectors need to suppress their own infection in addition to their targets to be effective. Gag68 TCR cloning and gene transfer into CD4(+)T cells enabled additional experiments with this unique specificity after the original clone senesced. Our data supports the idea that CD4(+)T cells can directly limit AIDS virus spread in T cells. Furthermore, Gag68 TCR transfer into CD4(+)T-cell clones with differing properties holds promise to better understand the suppressive effector mechanisms used by this important component of the antiviral response using the rhesus macaque model.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytolytic CD4(+)T cells; SIV; T-cell effectors; T-cell receptor; TCR transduction; Virus suppression; Virus-specific

Mesh:

Substances:

Year:  2016        PMID: 27017056      PMCID: PMC4860118          DOI: 10.1016/j.virol.2016.03.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry.

Authors:  Karina Godoy-Ramirez; Barbro Mäkitalo; Rigmor Thorstensson; Eric Sandström; Gunnel Biberfeld; Hans Gaines
Journal:  Cytometry A       Date:  2005-12       Impact factor: 4.355

2.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

Authors:  A Nichole Cline; Julian W Bess; Michael Piatak; Jeffrey D Lifson
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

3.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.

Authors:  A J Zajac; D G Quinn; P L Cohen; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.

Authors:  A Weiss; R L Wiskocil; J D Stobo
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

6.  The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.

Authors:  S R Riddell; P D Greenberg
Journal:  J Immunol Methods       Date:  1990-04-17       Impact factor: 2.303

7.  Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.

Authors:  Philip J Norris; Howell F Moffett; Otto O Yang; Daniel E Kaufmann; Margaret J Clark; Marylyn M Addo; Eric S Rosenberg
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques.

Authors:  Michael Schindler; Jan Münch; Matthias Brenner; Christiane Stahl-Hennig; Jacek Skowronski; Frank Kirchhoff
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Transduction with human telomerase reverse transcriptase immortalizes a rhesus macaque CD8+ T cell clone with maintenance of surface marker phenotype and function.

Authors:  Hanne Andersen; Eugene V Barsov; Matthew T Trivett; Charles M Trubey; Luis D Giavedoni; Jeffrey D Lifson; David E Ott; Claes Ohlén
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

10.  Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.

Authors:  Jason M Brenchley; Laura E Ruff; Joseph P Casazza; Richard A Koup; David A Price; Daniel C Douek
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

View more
  4 in total

1.  Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.

Authors:  Victor I Ayala; Matthew T Trivett; Eugene V Barsov; Sumiti Jain; Michael Piatak; Charles M Trubey; W Gregory Alvord; Elena Chertova; James D Roser; Jeremy Smedley; Alexander Komin; Brandon F Keele; Claes Ohlen; David E Ott
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

2.  CXCR5-Dependent Entry of CD8 T Cells into Rhesus Macaque B-Cell Follicles Achieved through T-Cell Engineering.

Authors:  Victor I Ayala; Claire Deleage; Matthew T Trivett; Sumiti Jain; Lori V Coren; Matthew W Breed; Joshua A Kramer; James A Thomas; Jacob D Estes; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2017-05-12       Impact factor: 6.549

Review 3.  Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?

Authors:  Jennifer A Juno; David van Bockel; Stephen J Kent; Anthony D Kelleher; John J Zaunders; C Mee Ling Munier
Journal:  Front Immunol       Date:  2017-01-23       Impact factor: 7.561

4.  T-cell responses to KSHV infection: a systematic approach.

Authors:  Romin Roshan; Nazzarena Labo; Matthew Trivett; Wendell Miley; Vickie Marshall; Lori Coren; Elena M Cornejo Castro; Hannah Perez; Benjamin Holdridge; Eliza Davis; Rodrigo Matus-Nicodemos; Victor I Ayala; Raymond Sowder; Kathleen M Wyvill; Karen Aleman; Christine Fennessey; Jeffrey Lifson; Mark N Polizzotto; Daniel Douek; Brandon Keele; Thomas S Uldrick; Robert Yarchoan; Claes Ohlen; David Ott; Denise Whitby
Journal:  Oncotarget       Date:  2017-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.